Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
Encouraging the use of pre-exposure prophylaxis (PrEP) depends on the way that HIV risk is communicated to subgroups that are traditionally at the highest risk. A new study found that interest in PrEP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback